Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 182

1.

Staphylococcus aureus products subvert the Burkholderia cenocepacia-induced inflammatory response in airway epithelial cells.

Ji Y, Bolhuis A, Watson ML.

J Med Microbiol. 2019 Nov 1. doi: 10.1099/jmm.0.001100. [Epub ahead of print]

PMID:
31674896
2.

Management of Steroid-Refractory Immune-Related Adverse Events.

Watson ML, Beardslee T.

Oncology (Williston Park). 2019 Aug 23;33(8). pii: 683727. No abstract available.

3.

Superconditioning TMS for examining upper motor neuron function in MND.

Calancie B, Young E, Watson ML, Wang D, Alexeeva N.

Exp Brain Res. 2019 Aug;237(8):2087-2103. doi: 10.1007/s00221-019-05573-4. Epub 2019 Jun 7.

PMID:
31175383
4.

Risk Factors and Outcomes Associated With Acquisition of Daptomycin and Linezolid-Nonsusceptible Vancomycin-Resistant Enterococcus.

Greene MH, Harris BD, Nesbitt WJ, Watson ML, Wright PW, Talbot TR, Nelson GE.

Open Forum Infect Dis. 2018 Oct 9;5(10):ofy185. doi: 10.1093/ofid/ofy185. eCollection 2018 Oct.

5.

Arginase overexpression and NADPH oxidase stimulation underlie impaired vasodilation induced by advanced glycation end products.

El-Bassossy HM, Neamatallah T, Balamash KS, Abushareb AT, Watson ML.

Biochem Biophys Res Commun. 2018 May 23;499(4):992-997. doi: 10.1016/j.bbrc.2018.04.036. Epub 2018 Apr 10.

PMID:
29627571
6.

Zingerone alleviates the delayed ventricular repolarization and AV conduction in diabetes: Effect on cardiac fibrosis and inflammation.

El-Bassossy HM, Al-Thubiani WS, Elberry AA, Mujallid MI, Ghareib SA, Azhar AS, Banjar ZM, Watson ML.

PLoS One. 2017 Dec 5;12(12):e0189074. doi: 10.1371/journal.pone.0189074. eCollection 2017.

7.

Emergency department procedural sedation for primary electrical cardioversion - a comparison with procedural sedations for other reasons.

Butler M, Froese P, Zed P, Kovacs G, MacKinley R, Magee K, Watson ML, Campbell SG.

World J Emerg Med. 2017;8(3):165-169. doi: 10.5847/wjem.j.1920-8642.2017.03.001.

8.

Cardioprotection by 6-gingerol in diabetic rats.

El-Bassossy HM, Elberry AA, Ghareib SA, Azhar A, Banjar ZM, Watson ML.

Biochem Biophys Res Commun. 2016 Sep 2;477(4):908-914. doi: 10.1016/j.bbrc.2016.06.157. Epub 2016 Jul 1.

PMID:
27378426
9.

Protective effect of zingerone on increased vascular contractility in diabetic rat aorta.

Ghareib SA, El-Bassossy HM, Elberry AA, Azhar A, Watson ML, Banjar ZM, Alahdal AM.

Eur J Pharmacol. 2016 Jun 5;780:174-9. doi: 10.1016/j.ejphar.2016.03.046. Epub 2016 Mar 25.

PMID:
27020549
10.

6-Gingerol alleviates exaggerated vasoconstriction in diabetic rat aorta through direct vasodilation and nitric oxide generation.

Ghareib SA, El-Bassossy HM, Elberry AA, Azhar A, Watson ML, Banjar ZM.

Drug Des Devel Ther. 2015 Nov 9;9:6019-26. doi: 10.2147/DDDT.S94346. eCollection 2015.

11.

Emergency Procedural Sedation With Propofol in Older Teenagers: Any Cause for Concern?

Campbell SG, MacPhee S, Butler M, Zed PJ, Froese P, Watson ML, MacKinley R.

Pediatr Emerg Care. 2015 Nov;31(11):762-5. doi: 10.1097/PEC.0000000000000447.

PMID:
26535498
12.
13.

Phosphoinositide 3-kinase alpha-dependent regulation of branching morphogenesis in murine embryonic lung: evidence for a role in determining morphogenic properties of FGF7.

Carter E, Miron-Buchacra G, Goldoni S, Danahay H, Westwick J, Watson ML, Tosh D, Ward SG.

PLoS One. 2014 Dec 2;9(12):e113555. doi: 10.1371/journal.pone.0113555. eCollection 2014.

14.

Electrical impedance myography correlates with standard measures of ALS severity.

Rutkove SB, Caress JB, Cartwright MS, Burns TM, Warder J, David WS, Goyal N, Maragakis NJ, Benatar M, Sharma KR, Narayanaswami P, Raynor EM, Watson ML, Shefner JM.

Muscle Nerve. 2014 Mar;49(3):441-3. doi: 10.1002/mus.24128. Epub 2013 Dec 19.

PMID:
24273034
15.

Altered gene expression patterns in muscle ring finger 1 null mice during denervation- and dexamethasone-induced muscle atrophy.

Furlow JD, Watson ML, Waddell DS, Neff ES, Baehr LM, Ross AP, Bodine SC.

Physiol Genomics. 2013 Dec 1;45(23):1168-85. doi: 10.1152/physiolgenomics.00022.2013. Epub 2013 Oct 15.

16.

A study to evaluate safety and tolerability of repeated doses of tirasemtiv in patients with amyotrophic lateral sclerosis.

Shefner JM, Watson ML, Meng L, Wolff AA; Neals/Cytokinetics STUDY Team.

Amyotroph Lateral Scler Frontotemporal Degener. 2013 Dec;14(7-8):574-81. doi: 10.3109/21678421.2013.822517. Epub 2013 Aug 19.

PMID:
23952636
17.

Arginase inhibition alleviates hypertension in the metabolic syndrome.

El-Bassossy HM, El-Fawal R, Fahmy A, Watson ML.

Br J Pharmacol. 2013 Jun;169(3):693-703. doi: 10.1111/bph.12144.

18.

Electrical impedance myography as a biomarker to assess ALS progression.

Rutkove SB, Caress JB, Cartwright MS, Burns TM, Warder J, David WS, Goyal N, Maragakis NJ, Clawson L, Benatar M, Usher S, Sharma KR, Gautam S, Narayanaswami P, Raynor EM, Watson ML, Shefner JM.

Amyotroph Lateral Scler. 2012 Sep;13(5):439-45. doi: 10.3109/17482968.2012.688837. Epub 2012 Jun 7.

19.

Safety, tolerability and pharmacodynamics of a skeletal muscle activator in amyotrophic lateral sclerosis.

Shefner J, Cedarbaum JM, Cudkowicz ME, Maragakis N, Lee J, Jones D, Watson ML, Mahoney K, Chen M, Saikali K, Mao J, Russell AJ, Hansen RL, Malik F, Wolff AA; Neals/Cytokinetics Study Team.

Amyotroph Lateral Scler. 2012 Sep;13(5):430-8. doi: 10.3109/17482968.2012.684214. Epub 2012 May 16.

PMID:
22591195
20.

Defining the contribution of AMP-activated protein kinase (AMPK) and protein kinase C (PKC) in regulation of glucose uptake by metformin in skeletal muscle cells.

Turban S, Stretton C, Drouin O, Green CJ, Watson ML, Gray A, Ross F, Lantier L, Viollet B, Hardie DG, Marette A, Hundal HS.

J Biol Chem. 2012 Jun 8;287(24):20088-99. doi: 10.1074/jbc.M111.330746. Epub 2012 Apr 17.

21.

A cell-autonomous role for the glucocorticoid receptor in skeletal muscle atrophy induced by systemic glucocorticoid exposure.

Watson ML, Baehr LM, Reichardt HM, Tuckermann JP, Bodine SC, Furlow JD.

Am J Physiol Endocrinol Metab. 2012 May 1;302(10):E1210-20. doi: 10.1152/ajpendo.00512.2011. Epub 2012 Feb 21.

22.

Chronic effects of palmitate overload on nutrient-induced insulin secretion and autocrine signalling in pancreatic MIN6 beta cells.

Watson ML, Macrae K, Marley AE, Hundal HS.

PLoS One. 2011;6(10):e25975. doi: 10.1371/journal.pone.0025975. Epub 2011 Oct 5.

23.

Comparison of infrared thermography and laser speckle contrast imaging for the dynamic assessment of digital microvascular function.

Pauling JD, Shipley JA, Raper S, Watson ML, Ward SG, Harris ND, McHugh NJ.

Microvasc Res. 2012 Mar;83(2):162-7. doi: 10.1016/j.mvr.2011.06.012. Epub 2011 Jul 1.

PMID:
21763703
24.

Multipoint incremental motor unit number estimation as an outcome measure in ALS.

Shefner JM, Watson ML, Simionescu L, Caress JB, Burns TM, Maragakis NJ, Benatar M, David WS, Sharma KR, Rutkove SB.

Neurology. 2011 Jul 19;77(3):235-41. doi: 10.1212/WNL.0b013e318225aabf. Epub 2011 Jun 15.

25.

Expression and agonist responsiveness of CXCR3 variants in human T lymphocytes.

Korniejewska A, McKnight AJ, Johnson Z, Watson ML, Ward SG.

Immunology. 2011 Apr;132(4):503-15. doi: 10.1111/j.1365-2567.2010.03384.x. Epub 2011 Jan 24.

26.

Intake of artificially sweetened soft drinks and risk of preterm delivery.

Bursey RG, Watson ML.

Am J Clin Nutr. 2010 Nov;92(5):1277-8; author reply 1278-80. doi: 10.3945/ajcn.110.000984. Epub 2010 Sep 15. No abstract available.

PMID:
20844066
27.

A selective allosteric potentiator of the M1 muscarinic acetylcholine receptor increases activity of medial prefrontal cortical neurons and restores impairments in reversal learning.

Shirey JK, Brady AE, Jones PJ, Davis AA, Bridges TM, Kennedy JP, Jadhav SB, Menon UN, Xiang Z, Watson ML, Christian EP, Doherty JJ, Quirk MC, Snyder DH, Lah JJ, Levey AI, Nicolle MM, Lindsley CW, Conn PJ.

J Neurosci. 2009 Nov 11;29(45):14271-86. doi: 10.1523/JNEUROSCI.3930-09.2009.

28.

Haem oxygenase-1 induction protects against tumour necrosis factor alpha impairment of endothelial-dependent relaxation in rat isolated pulmonary artery.

El-Bassossy HM, El-Maraghy NN, El-Fayoumi HM, Watson ML.

Br J Pharmacol. 2009 Nov;158(6):1527-35. doi: 10.1111/j.1476-5381.2009.00419.x. Epub 2009 Oct 20.

29.

Voltage-independent calcium channels mediate lipopolysaccharide-induced hyporeactivity to endothelin-1 in the rat aorta.

El-Awady MS, Smirnov SV, Watson ML.

Am J Physiol Heart Circ Physiol. 2009 May;296(5):H1408-15. doi: 10.1152/ajpheart.01305.2008. Epub 2009 Mar 13.

30.
31.

Desensitization of the soluble guanylyl cyclase/cGMP pathway by lipopolysaccharide in rat isolated pulmonary artery but not aorta.

El-Awady MS, Smirnov SV, Watson ML.

Br J Pharmacol. 2008 Dec;155(8):1164-73. doi: 10.1038/bjp.2008.358. Epub 2008 Sep 22.

32.

Interleukin 13 increases contractility of murine tracheal smooth muscle by a phosphoinositide 3-kinase p110delta-dependent mechanism.

Farghaly HS, Blagbrough IS, Medina-Tato DA, Watson ML.

Mol Pharmacol. 2008 May;73(5):1530-7. doi: 10.1124/mol.108.045419. Epub 2008 Feb 14.

PMID:
18276774
33.

Phosphoinositide 3-kinase signalling in lung disease: leucocytes and beyond.

Medina-Tato DA, Ward SG, Watson ML.

Immunology. 2007 Aug;121(4):448-61. Review.

34.

Aspiration pneumonitis requiring intubation after procedural sedation and analgesia: a case report.

Cheung KW, Watson ML, Field S, Campbell SG.

Ann Emerg Med. 2007 Apr;49(4):462-4. Epub 2006 Nov 3.

PMID:
17084944
35.

Leukocyte navigation mechanisms as targets in airway diseases.

Medina-Tato DA, Watson ML, Ward SG.

Drug Discov Today. 2006 Oct;11(19-20):866-79. Epub 2006 Sep 7. Review.

PMID:
16997136
36.

Muscarinic receptor-mediated GTP-Eu binding in the hippocampus and prefrontal cortex is correlated with spatial memory impairment in aged rats.

Zhang HY, Watson ML, Gallagher M, Nicolle MM.

Neurobiol Aging. 2007 Apr;28(4):619-26. Epub 2006 Apr 5.

PMID:
16600436
37.

An unusual cause of fitting in a 20 year old girl.

Beckett D, Malins A, Watson ML, Kelly CA.

Acute Med. 2006;5(2):65-7.

PMID:
21611636
38.
39.

Pharmacogenomic data submissions to the FDA: clinical case studies.

Trepicchio WL, Williams GA, Essayan D, Hall ST, Harty LC, Shaw PM, Spear BB, Wang SJ, Watson ML.

Pharmacogenomics. 2004 Jul;5(5):519-24. No abstract available.

PMID:
15212589
40.

Association of mutation position in polycystic kidney disease 1 (PKD1) gene and development of a vascular phenotype.

Rossetti S, Chauveau D, Kubly V, Slezak JM, Saggar-Malik AK, Pei Y, Ong AC, Stewart F, Watson ML, Bergstralh EJ, Winearls CG, Torres VE, Harris PC.

Lancet. 2003 Jun 28;361(9376):2196-201.

PMID:
12842373
41.

NEXUS study needs Canadian results.

Pauls M, Watson ML.

Can Fam Physician. 2002 Oct;48:1610. No abstract available.

42.

Elements of informed consent for pharmacogenetic research; perspective of the pharmacogenetics working group.

Anderson DC, Gomez-Mancilla B, Spear BB, Barnes DM, Cheeseman K, Shaw PM, Friedman J, McCarthy A, Brazell C, Ray SC, McHale D, Hashimoto L, Sandbrink R, Watson ML, Salerno RA, Cohen N, Lister CE; Pharmacogenetics Working Group.

Pharmacogenomics J. 2002;2(5):284-92. Review. No abstract available.

43.

Managing the patient with polycystic kidney disease.

Gibson P, Watson ML.

Practitioner. 2002 Jun;246(1635):450-3. Review. No abstract available.

PMID:
12073704
44.

Chemokines--linking receptors to response.

Watson ML.

Immunology. 2002 Feb;105(2):121-4. Review. No abstract available.

45.

Characterization of initiated cells in N-methylnitrosourea-induced carcinogenesis of the CNS in the adult rat.

Kokkinakis DM, Watson ML, Honig LS, Rushing EJ, Mickey BE, Schold SC Jr.

Neuro Oncol. 2001 Apr;3(2):99-112. doi: 10.1093/neuonc/3.2.99.

46.

Investigation and treatment of patients with teeth affected by tooth substance loss: a review.

Watson ML, Burke FJ.

Dent Update. 2000 May;27(4):175-83. Review.

PMID:
11218452
47.

Recurrent (nonfamilial) hemangioblastomas involving spinal nerve roots: case report.

Raghavan R, Krumerman J, Rushing EJ, White CL 3rd, Chason DP, Watson ML, Coimbra C.

Neurosurgery. 2000 Dec;47(6):1443-8.

PMID:
11126917
48.
49.

A tale of two tribes.

Watson ML, Walker K, Gaskell S, Hope L, Graham M, Taylor S, Parker C, Abernethy A.

Nurs Times. 1999 Sep 15-21;95(37):34-5. No abstract available.

PMID:
10732622
50.

Burkholderia cepacia is resistant to the antimicrobial activity of airway epithelial cells.

Baird RM, Brown H, Smith AW, Watson ML.

Immunopharmacology. 1999 Nov;44(3):267-72.

PMID:
10598883

Supplemental Content

Loading ...
Support Center